Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia

References

• Munford RS, Suffredini AF. Sepsis, severe sepsis and septic shock. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia: Churchill Livingstone; 2010. 987–1010.
   Google Scholar
• Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 2007; 109:1574–83.
   PubMed Web of Science ®Google Scholar
• Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S, . Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis 2008;8:38.
   PubMed Web of Science ®Google Scholar
• Svaldi M, Hirber J, Lanthaler AI, Mayr O, Faes S, Peer E, . Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001;115:53–7.
   PubMed Web of Science ®Google Scholar
• Massaro KS, Costa SF, Leone C, Chamone DA. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis 2007;7:137.
   PubMed Web of Science ®Google Scholar
• Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 2008;36:396–407.
   PubMed Web of Science ®Google Scholar
• Engel A, Steinbach G, Kern P, Kern WV. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 1999;31:185–9.
   PubMed Web of Science ®Google Scholar
• Kallio R, Surcel HM, Bloigu A, Syrjälä H. C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 2000;36:889–94.
   PubMed Web of Science ®Google Scholar
• Ruokonen E, Nousiainen T, Pulkki K, Takala J. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 1999;18:283–5.
   PubMed Web of Science ®Google Scholar
• Shine B, de Beer FC, Pepys MB. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta 1981;117:13–23.
   PubMed Web of Science ®Google Scholar
• Rintala E, Irjala K, Nikoskelainen J. Value of measurement of C-reactive protein in febrile patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1992; 11:973–8.
   PubMed Web of Science ®Google Scholar
• Yonemori K, Kanda Y, Yamamoto R, Hamaki T, Suguro M, Chizuka A, . Clinical value of serial measurement of serum C-reactive protein level in neutropenic patients. Leuk Lymphoma 2001;41:607–14.
   PubMed Web of Science ®Google Scholar
• Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis 1995;21:114–21.
   PubMed Web of Science ®Google Scholar
• Pfäfflin A, Schleicher E. Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem 2009;393:1473–80.
   PubMed Web of Science ®Google Scholar
• Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206–17.
   PubMed Web of Science ®Google Scholar
• Erten N, Genc S, Besisik SK, Saka B, Karan MA, Tascioglu C. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients. J Chin Med Assoc 2004;67:217–21.
   PubMedGoogle Scholar
• Prat C, Sancho JM, Dominguez J, Xicoy B, Gimenez M, Ferra C, . Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma 2008;49:1752–61.
   PubMed Web of Science ®Google Scholar
• Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, . 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730–51.
   PubMed Web of Science ®Google Scholar
• Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644–55.
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–6.
   PubMed Web of Science ®Google Scholar
• Sarmati L, Beltrame A, Dori L, Maffongelli G, Cudillo L, De Angelis G, . Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. Am J Hematol 2010;85:380–3.
   PubMed Web of Science ®Google Scholar
• Sauer M, Tiede K, Fuchs D, Gruhn B, Berger D, Zintl F. Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis. Bone Marrow Transplant 2003;31:1137–42.
   PubMed Web of Science ®Google Scholar
• Madani TA. Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection 2000;28:367–73.
   PubMed Web of Science ®Google Scholar
• Malagola M, Peli A, Damiani D, Candoni A, Tiribelli M, Martinelli G, . Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases. Eur J Haematol 2008;81:354–63.
   PubMed Web of Science ®Google Scholar
• Sung L, Gamis A, Alonzo TA, Buxton A, Britton K, Deswarte-Wallace J, . Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia. Cancer 2009;115:1100–8.
   PubMed Web of Science ®Google Scholar
• Gencer S, Salepci T, Ozer S. Evaluation of infectious etiology and prognostic risk factors of febrile episodes in neutropenic cancer patients. J Infect 2003;47:65–72.
   PubMed Web of Science ®Google Scholar
• Hämäläinen S, Juutilainen A, Kuittinen T, Nousiainen T, Matinlauri I, Pulkki K, . Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein. Leuk Lymphoma 2010;51:1040–6.
   PubMed Web of Science ®Google Scholar
• Juutilainen A, Hämäläinen S, Matinlauri I, Kuittinen T, Nousiainen T, Pulkki K, . Serial plasma lactate measurements in haematological patients with neutropenic fever. Scand J Infect Dis 2010;42:102–8.
   PubMed Web of Science ®Google Scholar
• Hämäläinen S, Juutilainen A, Matinlauri I, Kuittinen T, Ruokonen E, Koivula I, . Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C-reactive protein. Eur J Haematol 2009;83:251–7.
   PubMed Web of Science ®Google Scholar
• Blijlevens NM, Donnelly JP, Meis JF, De Keizer MH, De Pauw BE. Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 2000;7:889–92.
   PubMedGoogle Scholar
• Kanamaru A, Tatsumi Y. Microbiological data for patients with febrile neutropenia. Clin Infect Dis 2004;39(Suppl 1): S7–10.
   Google Scholar
• Puig N, de la Rubia J, Jarque I, Salavert M, Montesinos P, Sanz J, . A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation. Int J Hematol 2007; 86:186–92.
   PubMed Web of Science ®Google Scholar
• Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 2004;39(Suppl 1):S25–31.
   PubMed Web of Science ®Google Scholar
• Prat C, Domínguez J, Andreo F, Blanco S, Pallarés A, Cuchillo F, . Procalcitonin and neopterin correlation with aetiology and severity of pneumonia. J Infect 2006;52: 169–77.
   PubMed Web of Science ®Google Scholar